IGC Pharma (IGC) Intangibles (2011 - 2026)
IGC Pharma's Intangibles was $5.27 million in Q4 2026, up 184.4% from $1.85 million a year earlier and up 3.3% from the prior quarter.
Powered by 
Analysis
IGC Pharma (IGC) Intangibles (2011 - 2026) Analysis & Trends
From Q3 2012 onward, IGC Pharma has reported Intangibles for 52 quarters.
- Intangibles has now increased for eight consecutive years, with a five-year compound annual growth rate of 66.9% (FY2021 to FY2026).
- In earlier years, Intangibles was $1.85 million in FY2025 (+14.6%), $1.62 million in FY2024 (+38.1%), $1.17 million in FY2023 (+27.6%) and $917,000 in FY2022 (+125.3%).
- The Q4 2026 figure marks the highest quarterly Intangibles in data going back to Q3 2012.
- Compared with a year earlier, Intangibles has increased for 25 straight quarters, with growth averaging 89.4% over the last eight quarters.
- The year-over-year growth in Intangibles has ranged between 10.9% (Q3 2022) and 184.4% (Q4 2026) over the last five years.
- Per Business Quant data, IGC's Intangibles in the three quarters before Q4 2026 was $5.1 million (Q3 2026), $4.88 million (Q2 2026) and $2 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 18.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 48.23 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 49.14 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 24.98 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 42.07 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 37.72 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 20.49 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 14.03 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 47.05 Bn |
| 10 | IGC Pharma | 24.10 Mn | 21.34 Mn | 55,000.00 | 5.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 5.27 Mn |
| Dec 31, 2025 | 5.10 Mn |
| Sep 30, 2025 | 4.88 Mn |
| Jun 30, 2025 | 2.00 Mn |
| Mar 31, 2025 | 1.85 Mn |
| Dec 31, 2024 | 1.87 Mn |
| Sep 30, 2024 | 1.80 Mn |
| Jun 30, 2024 | 1.72 Mn |
| Mar 31, 2024 | 1.62 Mn |
| Dec 31, 2023 | 1.18 Mn |
| Sep 30, 2023 | 1.18 Mn |
| Jun 30, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.17 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 952,000.00 |
| Jun 30, 2022 | 937,000.00 |
| Mar 31, 2022 | 917,000.00 |
| Dec 31, 2021 | 426,000.00 |
| Sep 30, 2021 | 411,000.00 |
| Jun 30, 2021 | 405,000.00 |
API Access
IGC Pharma Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=IGC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "IGC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=IGC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();